These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. In vivo regulation of beta-adrenergic receptors on human mononuclear leukocytes: assessment of receptor number, location, and function after posture change, exercise, and isoproterenol infusion. DeBlasi A; Maisel AS; Feldman RD; Ziegler MG; Fratelli M; DiLallo M; Smith DA; Lai CY; Motulsky HJ J Clin Endocrinol Metab; 1986 Oct; 63(4):847-53. PubMed ID: 3018026 [TBL] [Abstract][Full Text] [Related]
26. Effects of pressure overload, left ventricular hypertrophy on beta-adrenergic receptors, and responsiveness to catecholamines. Vatner DE; Homcy CJ; Sit SP; Manders WT; Vatner SF J Clin Invest; 1984 May; 73(5):1473-82. PubMed ID: 6325505 [TBL] [Abstract][Full Text] [Related]
27. Tissue-type plasminogen activator release in healthy subjects and hypertensive patients: relationship with beta-adrenergic receptors and the nitric oxide pathway. Giannarelli C; Virdis A; De Negri F; Duranti E; Magagna A; Ghiadoni L; Salvetti A; Taddei S Hypertension; 2008 Aug; 52(2):314-21. PubMed ID: 18574075 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase. Vatner DE; Asai K; Iwase M; Ishikawa Y; Wagner TE; Shannon RP; Homcy CJ; Vatner SF J Clin Invest; 1998 May; 101(9):1916-22. PubMed ID: 9576756 [TBL] [Abstract][Full Text] [Related]
29. Beta-adrenergic receptors in human leukocyte subpopulations. Landmann R Eur J Clin Invest; 1992 Oct; 22 Suppl 1():30-6. PubMed ID: 1333965 [TBL] [Abstract][Full Text] [Related]
30. Agonist-promoted high affinity state of the beta-adrenergic receptor in human neutrophils: modulation by corticosteroids. Davies AO; Lefkowitz RJ J Clin Endocrinol Metab; 1981 Oct; 53(4):703-8. PubMed ID: 6116722 [TBL] [Abstract][Full Text] [Related]
31. Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase. Williams LT; Gore TB; Lefkowitz RJ J Clin Invest; 1977 Feb; 59(2):319-24. PubMed ID: 13086 [TBL] [Abstract][Full Text] [Related]
32. Acute reduction in human platelet alpha 2-adrenoreceptor affinity for agonist by endogenous and exogenous catecholamines. Hollister AS; FitzGerald GA; Nadeau JH; Robertson D J Clin Invest; 1983 Oct; 72(4):1498-505. PubMed ID: 6138365 [TBL] [Abstract][Full Text] [Related]